Professional Intermediate, Fine Chemical, Natural Extracts manufacturer

Committed to high-end, high-quality Bile Acid Products

Understand more

Attentive Careful Elaborate

Details make a difference

Refined management

Strive to achieve high -quality products at one time，Improve product production standards，Provide excellent high -quality products. Perfect stocking、Production、Delivery process，Scientific management，Refined production.

Market segments

Guide the direction of market products; Professional product response Information; Professional business operation model.

Technical support

Complete laboratory technical indicators，Product technology is based on the EU、China、Japan、American standard technology，Provide high -tech products that meet relevant requirements，At the same time，Enterprises have high -end technical talents in market segments.

Integration of resources

Combined with years of processing、Production、Sale、Management experience，Integrated areas and resources involved in products，Provide customers with high -end excellent quality products.

Company profile

Focus on global markets

ABOUT US

Xinniushan biology has been producing cholic acid products for more than 16 years. The company has its own independent workshop, Product R & D, product upgrading, product production capacity, with an independent laboratory for Product R & D and testing, in line with international standards. The high-quality cholic acid products are exported to Russia, Japan, India, Europe and the United States and other countries, recieving domestic and foreign customers' trust and praise.

Brand product

Persist in innovation Production of high -quality products Serve global customers

News

Follow the real -time dynamics of the peers

Lithocholic acid decreases the stability of nuclear receptor PPAR α mRNA by up-regulating miR-21 expression

Lithocholic acid induces the up-regulation of EGR1 and Mir-21 by activating ERK1/2 signaling pathway in hepatocytes, mir-21 acts on the 3' UTR regulatory region to reduce the stability of PPAR α mRNA, thereby reducing PPAR α gene and protein expression levels.

Industry news